This report providees researchers and government officials with an understanding of how ethics are created, monitored, and enforced across scientific disciplines and across borders.
The Securing American Science and Technology Act of 2019 would standardize how US Government agencies deal with academic espionage.
While biosecurity experts critically examine the funding sources of biological research, they rarely turn their gaze inward on their own community.
In the wake of CRISPR babies, there is an urgent need to better regulate and debate whether, when and how related research should be done.
A newly expanded genetic alphabet that includes four synthetic nucleotides highlights the need for strict boundaries on their use.
The federal government has a short list of regulated organisms. But the government’s ban focuses on the organisms themselves, rather than the genetic instructions for making them. Because the government has not published those sequences, the companies must decide for themselves whether a mail order request is potentially dangerous.
This paper offers an analytical framework is used to assess the risks and benefits of such dual use research, and relevant components of biosecurity policy and the biodefense enterprise (including the acquisition of medical countermeasures) in the United States are discussed.
Advances in the field of biotechnology and synthetic biology are becoming increasingly accessible to actors wishing to do harm, while scientists and policymakers have become increasingly aware that the current regulatory framework may not be adequate.
Controversial lab studies that modify bird flu viruses in ways that could make them riskier to humans will soon resume after being on hold for more than 4 years.